Gene Query: MRPL30

Dataset Description Geneva Score
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 29.75
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 29.75
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 28.49
ETV7 and interferon response 27.89
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 27.89
HNRNPL and its RNA Targets in Prostate Cancer 27.08
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 27.08
RIG-I and MDA5 fRIP during KSHV lytic reactivation 19.92
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 19.21
Overexpression of NFIB and YBX1 in MCF-7 cells 17.17
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 15.81
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 14.6
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 14.01
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 14.01
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 13.29
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 13.25
Mitochondrial dsRNA triggers antiviral signalling in humans 12.85
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 12.54
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 11.87
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 11.87
Single-nucleotide-resolution mapping of HBV promoters using CAGE 11.69
A transcriptome-wide divergence in protein translation scales with LIN28B expression 11.65
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 11.45
ARID1A regulates condensin II distribution and chromosomal partition 11.45
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 11.17
K562 polyA RNA-Seq 10.82
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 10.53
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 10.23
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 10.11
Lysine benzoylation is a novel histone mark [RNA-seq] 10.09
Lysine benzoylation is a novel histone mark 10.09
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 10.06
Cellular response to hepatitis E virus (HEV) infection 10.0
Tracking distinct RNA populations using efficient and reversible covalent chemistry 9.64
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 9.61
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 9.44
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 9.35
IDH3a KO RNA-seq 9.13
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 8.89
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 8.79
An RNA-centric dissection of host complexes controlling flavivirus infection 8.74
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 8.74
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 8.61
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 8.42
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 8.42
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 8.41
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 8.41
Cajal bodies are linked to genome conformation [RNA-Seq] 8.18
Cajal bodies are linked to genome conformation 8.18
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 8.17
Tracking of dCas9-methyltransferase footprints 8.17
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 8.07
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 8.06
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 8.03
EP400 is required for Max and MCPyV mediated gene activation 7.75
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 7.74
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 7.74
NRDE2 negatively regulates nuclear exosome functions 7.67
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 7.67
Developmental stage specific chromosome architecture in human erythroid cells 7.63
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 7.63
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 7.58
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 7.53
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 7.53
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 7.49
Glioblastoma stem cells infected by ZIKA virus 7.42
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 7.32
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 7.31
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 7.31
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 7.28
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 7.28
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 7.26
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 7.21
Sensing self and nonself circular RNAs 7.18
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 7.12
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 7.12
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 7.09
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 7.09
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 7.08
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 6.83
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 6.83
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 6.8
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 6.79
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 6.78
Solid phase chemistry to covalently and reversibly capture thiolated RNA 6.78
RNA-seq analysis of differentiating human erythroblasts 6.74
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 6.63
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 6.62
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 6.6
RNA-seq of YB5 cells treated with Proscillaridin A 6.59
TCF7L1 knockdown in pancreatic cancer 6.59
Regulation of protein translation during mitosis 6.57
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 6.55
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 6.51
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 6.44
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.39
Co-transcriptional loading of RNA export factors shapes the human transcriptome 6.39
RNAseq of HEK293 cells after Chtop knockdown 6.39
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 6.39
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 6.39
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 6.39
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 6.34
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 6.32
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 6.31
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 6.24
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 6.22
Generating Patterned Kidney Organoids for Studying Development and Diseases 6.2
Paxillin regulates genomic networks in prostate cancer [LNCaP] 6.18
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 6.14
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 5.98
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 5.93
Effect of CHKA knockdown on C4-2 cell transcriptome 5.88
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 5.86
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 5.81
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 5.8
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 5.77
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 5.77
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 5.76
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 5.76
Transcriptomic analyssis following EHMT1/2 inhibition 5.71
The regulartory role of ZCCHC24 in splicing machinery 5.68
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 5.62
An acquired vulnerability of drug resistant melanoma with therapeutic potential 5.62
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 5.61
Mapping interactions for the TNIP2 hub protein 5.6
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 5.55
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 5.53
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 5.53
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 5.48
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 5.48
Global analysis of enhancer targets: Mosaic-seq 5.4
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 5.38
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 5.35
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 5.35
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 5.33
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 5.3
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 5.3
A role for ZNF598 in post-transcriptional gene regulation 5.25
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 5.24
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 5.24
Effect of ILF3 on translation during homeostasis and the antiviral response 5.21
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 5.2
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 5.2
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 5.18
Identification of transcription start sites for human A549 cell line using ReCappable-seq 5.17
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 5.16
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 5.13
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 5.13
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 5.11
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 5.08
RNA sequencing of human mammary epithelial cells 5.03
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 5.0
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 4.99
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 4.96
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 4.94
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 4.93
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.92
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 4.92
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 4.91
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 4.86
Identification of global regulators of T-helper cell lineage specification 4.86
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 4.86
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 4.85
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 4.85
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 4.84
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 4.84
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 4.84
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 4.83
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 4.82
Transcriptome analysis in Neobractatin treated cells 4.82
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 4.79
Genome wide expression change by RNF168 knocking down in NEC cells 4.76
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 4.76
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 4.7
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 4.7
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 4.69
MeRIP-seq for heat shock in B-cell lymphoma cells 4.68
A Unique Epigenomic Landscape Defines Human Erythropoiesis 4.65
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 4.65
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 4.59
Small-molecule targeting of brachyury transcription factor addiction in chordoma 4.54
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 4.51
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 4.51
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 4.51
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 4.5
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 4.49
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 4.47
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 4.47
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 4.46
hnRNP C is a key regulator of protein synthesis in mitosis 4.44
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 4.43
MYC dependent mRNA translation shapes gene expression and cell biology 4.42
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 4.4
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 4.38
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 4.38
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 4.38
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 4.36
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 4.36
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 4.36
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 4.35
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 4.34
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.31
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 4.29
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 4.25
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 4.25
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 4.25
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 4.25
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 4.24
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 4.24
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 4.21
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 4.21
Gene expression in GBM with Cav3.2 inhibition 4.21
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 4.2
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 4.2
The landscape of alternative splicing in aggressive prostate cancers 4.19
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 4.18
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 4.17
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 4.17
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 4.16
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 4.14
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 4.14
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 4.14
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 4.13
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 4.12
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 4.09
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 4.06
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 4.06
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 4.06
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 4.05
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 4.05
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  4.05
Human cell line and subcutaneous tumor 4.02
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 3.99
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 3.99
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 3.96
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 3.95
Selective expression of long non-coding RNAs in a breast cancer cell progression model 3.95
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 3.93
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 3.93
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 3.93
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 3.93
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 3.93
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 3.92
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 3.88
Genome-wide chromatin analysis of Ewing sarcoma 3.88
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 3.88
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 3.86
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 3.86
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 3.85
U1 snRNP telescripting regulates size-function stratified human genome 3.85
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 3.84
Human HAP1 cells before and after nutrient deprivation 3.81
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 3.81
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 3.8
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 3.8
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 3.75
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 3.75
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.72
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 3.72
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 3.72
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 3.7
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 3.7
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 3.67
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 3.64
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.63
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 3.63
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 3.62
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 3.57
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 3.56
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 3.55
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 3.55
Hypoxic transcriptome of SQ20B human head and neck cancer cells 3.55
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 3.55
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 3.54
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 3.52
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 3.52
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 3.51
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 3.45
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 3.44
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 3.44
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 3.43
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 3.43
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 3.42
The pause-initiation limit restricts transcription activation in human cells 3.42
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 3.42
A map of gene expression in neutrophil-like cell lines 3.41
HEK293 Heat-shock experiment 3.4
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 3.39
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 3.39
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 3.38
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 3.38
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 3.34
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 3.29
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 3.29
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.29
Gene expression profile in breast cancer cells 3.29
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.28
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 3.28
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.27
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.27
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 3.24
scRNASeq analysis of cycling cardiomyocytes 3.21
Novel Targeting of Transcription and Metabolism in Glioblastoma 3.19
Biological effect of chronic mistranslation in mammalian cells 3.12
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 3.11
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 3.11
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 3.11
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.09
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 3.08
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 3.05
Gene expression analysis of dengue-infected cells 3.03
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.01
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 3.01
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 3.0
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 2.99
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 2.99
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 2.93
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 2.92
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 2.92
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 2.91
RNA-Seq of PRMT1 overexpression ECA109 cells 2.89
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 2.87
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 2.86
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.85
PRDM1 inhibits proliferation of human colon cancer organoids 2.83
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.81
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 2.79
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 2.77
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 2.77
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 2.77
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.77
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.75
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.74
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 2.74
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.72
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.71
Transcriptome-wide modulation of splicing by the exon junction complex 2.7
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 2.56
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 2.56
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 2.56
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.56
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.55
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.49
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 2.46
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 2.45
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 2.41
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 2.35
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.31
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 2.23
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 2.23
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 2.2
Iron response of HepG2 cells 2.17
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.15
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 2.14
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 2.13
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 2.12
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 2.12
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.11
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.1
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.1
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 2.09
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 2.09
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 2.09
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 2.05
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 2.04
MARS Seq data from human cortical organoids 2.04
EWSR1 influences alternative splicing through direct and indirect mechanisms 2.02
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 2.01
Functional role of CPPED1 in trophoblasts. 1.99
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.97
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.97
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 1.96
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 1.93
Impact on erythroid progenitor type on erythroid differntiation 1.91
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.91
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.91
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 1.89
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.88
Gene expression changes due to PARP knockdown in human cells 1.83
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 1.8
Systematic discovery of endogenous human ribonucleoprotein complexes 1.79
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.79
ARS2 is a general suppressor of pervasive transcription [RNAseq] 1.77
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 1.73
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 1.73
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 1.72
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.72
RNA-seq of IL-4 stimulated human keratinocytes 1.71
RNA seq with AML (NB4) cells upon FTO inhibition 1.7
RNA sequencing of primary human platelets and in vitro cell lines 1.69
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.66
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 1.65
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.64
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.64
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 1.61
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 1.61
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 1.61
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 1.61
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.58
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 1.56
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 1.56
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.55
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 1.55
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 1.54
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 1.54
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 1.52
Gene expression profiling of human and murine in vitro muscle differentiation 1.51
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.5
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.5
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.49
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.47
MicroRNA-125a-5p overexpression in human macrophages 1.44
Identification of renal resident macrophages across species [C1] 1.35
Expression charcaterization of an internal protocol developed to differentiate RPE cells 1.31
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 1.29
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.29
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 1.27
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.24
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.22
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.22
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.19
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.19
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 1.19
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 1.19
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 1.18
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.18
Functional significance of the HIV-1 Tat signature amino acid residues 1.18
HBEC-shp53-PCHD7 1.16
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.12
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 1.12
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.1
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 1.09
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.07
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 1.06
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 1.05
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.04
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.04
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 1.04
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 1.03
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.01
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 0.96
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.92
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 0.91
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.89
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.88
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 0.87
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.87
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.87
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 0.85
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.81
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.74
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.73
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.73
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 0.73
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.67
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.65
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 0.64
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.6
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.6
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 0.58
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 0.58
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.55
SLAM-seq for K562 endogenous mRNA decay 0.52
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.5
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.48
Identification of global XBP1s target gene expression in human prostate cancer cells 0.47
Global transcriptome analysis of WT versus HEB-/- hESCs 0.4
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 0.4
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.39
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.39
CDK4/6 inhibitor resistance in prostate cancer 0.38
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 0.38
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.32
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.31
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.31
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.31
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 0.27
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.25
p53 activity results in DNA replication fork processivity 0.23
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.23
Myc activation coordinates gene transcription and protein translation responses 0.23
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 0.23
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.23
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.2
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.15
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.15
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.13
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.13
Determining mRNA half-lives on a transcriptome-wide scale 0.11
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.1
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 0.1
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.07
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.07
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.04
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 0.02
Function and hormonal regulation of GATA3 in human first trimester placentation 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.02
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.01
SF3B1 Degron knockdown RNA-seq 0.0
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation